Skip to main content

Hennion & Walsh Asset Management, Inc.

Source: SEC Form 13F · as of Mar 2026

Hennion & Walsh Asset Management, Inc. holds 47 biotech & pharma companies tracked by BioSniper, totaling $139.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

47

Total value held

$139.8M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Cogent Biosciences, Inc. (COGT)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
COGTCogent Biosciences, Inc.326,472$12.6M
TEVATeva Pharmaceutical Industries Limited337,044$10.2M
JAZZJazz Pharmaceuticals plc49,352$9.3M
DAWNDay One Biopharmaceuticals, Inc.367,134$7.9M
KALVKalVista Pharmaceuticals, Inc.375,995$7.6M
OLMAOlema Pharmaceuticals, Inc.481,485$7.2M
AXSMAxsome Therapeutics, Inc.36,633$6.2M
ARDXARDELYX, INC.1,001,481$6.0M
SUPNSUPERNUS PHARMACEUTICALS, INC.88,454$4.6M
GRFSGrifols S.A.520,136$4.2M
GILDGILEAD SCIENCES, INC.27,272$3.8M
INCYIncyte Corp.37,138$3.5M
VRDNViridian Therapeutics, Inc.\DE174,894$3.4M
TVTXTravere Therapeutics, Inc.113,511$3.4M
KNSAKiniksa Pharmaceuticals International, plc67,341$3.2M
IBRXImmunityBio, Inc.407,444$3.1M
PROKPROKIDNEY CORP.1,611,693$2.9M
ANNXAnnexon, Inc.509,689$2.8M
KURAKura Oncology, Inc.335,212$2.7M
CMPSCOMPASS Pathways plc487,674$2.7M
OCGNOcugen, Inc.1,276,725$2.3M
IMVTImmunovant, Inc.91,009$2.3M
ACADACADIA PHARMACEUTICALS INC100,729$2.2M
NTLAIntellia Therapeutics, Inc.159,803$2.0M
ORICOric Pharmaceuticals, Inc.160,054$2.0M
APLSApellis Pharmaceuticals, Inc.50,374$2.0M
NUVBNuvation Bio Inc.450,594$1.9M
ZVRAZEVRA THERAPEUTICS, INC.177,163$1.7M
CLDXCelldex Therapeutics, Inc.47,525$1.5M
IOVAIOVANCE BIOTHERAPEUTICS, INC.409,464$1.4M
IMCRImmunocore Holdings plc47,127$1.4M
FLGTFulgent Genetics Inc.84,010$1.3M
LXRXLEXICON PHARMACEUTICALS, INC.848,138$1.3M
AGIOAGIOS PHARMACEUTICALS, INC.33,868$1.1M
QUREuniQure N.V.68,547$1.1M
RCKTRocket Pharmaceuticals Inc.287,815$1.0M
PRTAPROTHENA CORP PUBLIC LTD CO88,544$861K
RGNXREGENXBIO Inc.88,385$741K
ALTAltimmune, Inc.201,989$622K
AUTLAutolus Therapeutics plc440,206$607K
GERNGERON CORP396,632$591K
CCCCC4 Therapeutics, Inc.223,168$587K
REGNREGENERON PHARMACEUTICALS, INC.712$550K
ORGOOrganogenesis Holdings Inc.210,826$500K
BHVNBiohaven Ltd.44,793$379K
SNYSanofi4,590$221K
PLRXPLIANT THERAPEUTICS, INC.106,705$134K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.